$~0
At close: Nov 19, 1:58 PM EDT
Aridis Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aridis Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2022 | 2022-11-21 | $-0.47 | $-0.17 | -176.5 % |
Jun 2022 | 2022-08-16 | $-0.45 | $-0.06 | -650.0 % |
Mar 2022 | 2022-05-16 | $-0.44 | $-0.51 | 13.7 % |
Dec 2021 | 2022-03-31 | $-0.92 | $-0.41 | -124.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2022 | 2022-11-21 | $399.00K | $7.47M | -94.7 % |
Jun 2022 | 2022-08-16 | $292.00K | $10.46M | -97.2 % |
Mar 2022 | 2022-05-16 | $1.19M | $2.00M | -40.6 % |
Dec 2021 | 2022-03-31 | $570.00K | $1.90M | -70.0 % |
Aridis Pharmaceuticals (ARDS) is scheduled to report earnings on December 3, 2024. The last reported earnings were for reported on November 3, 2023 for Q3.
The Actual EPS was $0.00, which hit the estimate of $0.00.
The Actual Revenue was $417K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.